ReviewMedical sciences (Basel, Switzerland)2026
The Role of
Pietro Bellini, Francesco Dondi, Michela Cossandi, Gianluca Viganò, Carlo Cappelli, Elisa Gatta, Davide Lombardi, Riccardo Morandi, Claudio Casella, Luigi Spiazzi and 5 more
Abstract readReview
In one paragraphReview in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Francesco DondiNuclear Medicine, ASST Spedali Civili di Brescia and University of Brescia, 25123 Brescia, Italy.ORCID 0000-0003-4839-9033 Gianluca ViganòClinical Engineering, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Carlo CappelliDepartment of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, ASST Spedali Civili, 25123 Brescia, Italy.ORCID 0000-0003-4317-1232 Elisa GattaDepartment of Clinical and Experimental Sciences, SSD Endocrinologia, University of Brescia, ASST Spedali Civili, 25123 Brescia, Italy.ORCID 0000-0003-4460-3746 Davide LombardiOtolaryngology Unit, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Riccardo MorandiSurgical Clinic, Università Degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Claudio CasellaSurgical Clinic, Università Degli Studi di Brescia and ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Carlo RodellaHealth Physics Department, Spedali Civili, 25123 Brescia, Italy.
Federica SaianiHealth Physics Department, Spedali Civili, 25123 Brescia, Italy.
Chiara IngraitoHealth Physics Department, Spedali Civili, 25123 Brescia, Italy.
Valentina ZilioliNuclear Medicine, ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Francesco BertagnaNuclear Medicine, ASST Spedali Civili di Brescia and University of Brescia, 25123 Brescia, Italy.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Differentiated thyroid carcinoma (DTC) is the most common malignant endocrine tumor, with a generally favorable prognosis. Imaging, including iodine radioactive isotope scintigraphy (IRIS), is crucial for diagnosis and follow-up. While
Indexed as
Iodine RadioisotopesThyroid NeoplasmsHumansRadionuclide ImagingRadiopharmaceuticalsIodine-123Iodine-131Iodine RadioisotopesRadiopharmaceuticals123I scintigraphy124I PET/CT131I scintigraphydifferentiated thyroid cancer (DTC)radioiodine (RAI)
Identifiers
PMID41718114
PMCPMC12921828
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390